rs3735231

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_032581.4(HYCC1):​c.624A>G​(p.Ser208Ser) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.351 in 1,595,058 control chromosomes in the GnomAD database, including 99,736 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.35 ( 9511 hom., cov: 32)
Exomes 𝑓: 0.35 ( 90225 hom. )

Consequence

HYCC1
NM_032581.4 splice_region, synonymous

Scores

2
Splicing: ADA: 0.007816
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.04

Publications

23 publications found
Variant links:
Genes affected
HYCC1 (HGNC:24587): (hyccin PI4KA lipid kinase complex subunit 1) The protein encoded by this gene may play a part in the beta-catenin/Lef signaling pathway. Expression of this gene is down-regulated by beta-catenin. Defects in this gene are a cause of hypomyelination with congenital cataract (HCC). [provided by RefSeq, Oct 2008]
HYCC1 Gene-Disease associations (from GenCC):
  • hypomyelinating leukodystrophy 5
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.103).
BP6
Variant 7-22976212-T-C is Benign according to our data. Variant chr7-22976212-T-C is described in ClinVar as Benign. ClinVar VariationId is 21726.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.04 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.456 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HYCC1NM_032581.4 linkc.624A>G p.Ser208Ser splice_region_variant, synonymous_variant Exon 7 of 11 ENST00000432176.7 NP_115970.2 Q9BYI3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HYCC1ENST00000432176.7 linkc.624A>G p.Ser208Ser splice_region_variant, synonymous_variant Exon 7 of 11 1 NM_032581.4 ENSP00000403396.2 Q9BYI3-1

Frequencies

GnomAD3 genomes
AF:
0.353
AC:
53611
AN:
151996
Hom.:
9502
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.354
Gnomad AMI
AF:
0.404
Gnomad AMR
AF:
0.338
Gnomad ASJ
AF:
0.429
Gnomad EAS
AF:
0.470
Gnomad SAS
AF:
0.357
Gnomad FIN
AF:
0.349
Gnomad MID
AF:
0.282
Gnomad NFE
AF:
0.343
Gnomad OTH
AF:
0.320
GnomAD2 exomes
AF:
0.370
AC:
92045
AN:
248962
AF XY:
0.368
show subpopulations
Gnomad AFR exome
AF:
0.353
Gnomad AMR exome
AF:
0.386
Gnomad ASJ exome
AF:
0.418
Gnomad EAS exome
AF:
0.485
Gnomad FIN exome
AF:
0.348
Gnomad NFE exome
AF:
0.348
Gnomad OTH exome
AF:
0.367
GnomAD4 exome
AF:
0.351
AC:
506122
AN:
1442944
Hom.:
90225
Cov.:
29
AF XY:
0.351
AC XY:
252215
AN XY:
718942
show subpopulations
African (AFR)
AF:
0.351
AC:
11605
AN:
33052
American (AMR)
AF:
0.380
AC:
16963
AN:
44670
Ashkenazi Jewish (ASJ)
AF:
0.422
AC:
10980
AN:
26018
East Asian (EAS)
AF:
0.478
AC:
18906
AN:
39554
South Asian (SAS)
AF:
0.374
AC:
32105
AN:
85814
European-Finnish (FIN)
AF:
0.361
AC:
19042
AN:
52718
Middle Eastern (MID)
AF:
0.341
AC:
1955
AN:
5726
European-Non Finnish (NFE)
AF:
0.341
AC:
373243
AN:
1095628
Other (OTH)
AF:
0.357
AC:
21323
AN:
59764
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
14084
28168
42253
56337
70421
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12050
24100
36150
48200
60250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.353
AC:
53654
AN:
152114
Hom.:
9511
Cov.:
32
AF XY:
0.353
AC XY:
26219
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.354
AC:
14676
AN:
41486
American (AMR)
AF:
0.339
AC:
5173
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.429
AC:
1489
AN:
3472
East Asian (EAS)
AF:
0.472
AC:
2444
AN:
5182
South Asian (SAS)
AF:
0.358
AC:
1726
AN:
4826
European-Finnish (FIN)
AF:
0.349
AC:
3694
AN:
10570
Middle Eastern (MID)
AF:
0.272
AC:
80
AN:
294
European-Non Finnish (NFE)
AF:
0.343
AC:
23324
AN:
67984
Other (OTH)
AF:
0.323
AC:
680
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1825
3649
5474
7298
9123
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
538
1076
1614
2152
2690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.352
Hom.:
6949
Bravo
AF:
0.356
Asia WGS
AF:
0.387
AC:
1347
AN:
3478
EpiCase
AF:
0.340
EpiControl
AF:
0.342

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hypomyelination and Congenital Cataract Benign:3
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Apr 02, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.38
CADD
Benign
15
DANN
Benign
0.82
PhyloP100
1.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0078
dbscSNV1_RF
Benign
0.12
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3735231; hg19: chr7-23015831; COSMIC: COSV69016766; COSMIC: COSV69016766; API